When was Panaxia founded?

Panaxia was founded in 2009 and raised its 1st funding round 11 years after it was founded.

Where is Panaxia located?

Panaxia is headquartered in Lod, Israel.

Who is the current CEO of Panaxia?

Dadi Segal of Panaxia. They have also founded 1 company.

How many employees does Panaxia have?

As of Sep 30, 2026, the latest employee count at Panaxia is 52.

Is Panaxia a funded company?

Panaxia is a funded company, having raised a total of $***** in its 1st and only funding round, a Post IPO round on Apr 02, 2020.

When was the latest funding round of Panaxia?

Panaxia's latest funding was a $***** Post IPO round on Apr 02, 2020, with participation from 2 investors.

Where does Panaxia rank among its competitors?

Panaxia ranks 32nd amongst 246 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Terraflos, which secured $3.5M in Jun, 2026.

Who are the top competitors of Panaxia?

Panaxia's top competitors include Sanity Group, Terraflos and ZYUS Life Sciences. Among them, Terraflos secured the most recent funding round in June, 2026.

Panaxia - 2026 Company Profile, Team, Funding & Competitors

Panaxia is a public company based in Lod (Israel), founded in 2009 by Dadi Segal. It operates as a Provider of medical cannabis products. Panaxia has raised an undisclosed amount in funding. The company has 246 active competitors, including 27 funded and 56 that have exited. Its top competitors include companies like Sanity Group, Terraflos and ZYUS Life Sciences.

Company Details

Panaxia is a provider of medical cannabis products. It has developed various products such as dried powder inhaler, cannabis gel and jellies, and many more. These cannabis products help in treating various diseases like smoking addiction, swallowing dysfunction, and others.

Website: panaxia.co.il
Email ID: *****@panaxia.co.il
Phone Number: +972 **********

Key Metrics

Founded Year

2009

Location

Lod, Israel

Stage

Public

Latest Funding Round

Post IPO, Apr 02, 2020, $*****

Investors

Mor Investment House & 3 more

Ranked

32^nd among 246 active competitors

Employee Count

52 as on Sep 30, 2026

Similar Companies

Sanity Group & 297 more

Exit Details

Public

View Panaxia's full profile

Panaxia got listed on Nov 11, 2010.

Click here to take a look at Panaxia's IPO in detail

Panaxia has raised funding over 1 round. Its latest funding round was a Post IPO round on Apr 02, 2020 for $*****. 2 investors participated in its latest round. Panaxia has 4 institutional investors.

Here is the list of recent funding rounds of Panaxia:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 02, 2020	9979595	Post IPO	4985043	6681449	2861217	6150949

Access funding benchmarks and valuations. Sign up today!

View details of Panaxia's funding rounds and investors

The founders of Panaxia is Dadi Segal. Dadi Segal is the CEO of Panaxia.

Here are the details of Panaxia's key team members:

Dadi Segal: Founder & CEO of Panaxia.
Contact Info: 1 email address

View details of Panaxia's Founder profiles and Board Members

Panaxia's employee count trend

Panaxia has 52 employees as of Sep 26. Here is Panaxia's employee count trend over the years:

Uncover Panaxia's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Panaxia include Sanity Group, Terraflos and ZYUS Life Sciences. Here is the list of Top 10 competitors of Panaxia, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sanity Group 2011, Berlin (Germany), Acquired	Developer of cannabinoid-based pharmaceuticals and well-being products	$109M	HV Capital, TQ Ventures & 19 others	67/100
2nd	Terraflos 2021, Uruguay, Seed	Provider of cannabis medical products	$11.5M	Rainforest Capital, YaaX Capital & 4 others	59/100
3rd	ZYUS Life Sciences 2018, Saskatoon (Canada), Public	Developer of cannabis-derived therapeutics for multiple indications	$19.5M	Keyhorse Capital, Mammoth View	58/100
4th	gLeaf 2014, Frederick (United States), Acquired	Medical cannabis cultivator	$19.4M	Chicago Atlantic	57/100
5th	BOHECO 2013, Mumbai (India), Seed	Provider of cannabis-derived nutritional and wellness products	$9.95M	Absolem Technologies, S R B Buildtech LLP ... & 34 others	56/100
6th	Avicanna 2016, Toronto (Canada), Public	Developer of plant-derived cannabinoid-based products	$5.94M	Orthogonal Thinker, Barn Invest & 1 others	52/100
7th	IMCannabis 2008, Herzliya (Israel), Public	Developer of medical cannabis products	-	-	51/100
8th	Creso Pharma 2015, Perth (Australia), Acquired	Developer of cannabinoid therapeutics for multiple health purposes	-	EverBlu Capital, L1 Capital	51/100
9th	Little Green Pharma 2016, Perth (Australia), Public	Manufacturer of medicinal cannabis for therapeutic use	$1.91M	Fastforward Innovations	49/100
10th	Avextra 2004, Berlin (Germany), Series B	Provider of research & development services for medicinal cannabis products	$48.1M	Iberis Capital, Fastforward Innovations	46/100
32nd	Panaxia 2009, Lod (Israel), Public	Provider of medical cannabis products	-	Mor Investment House, Noked Capital & 2 others	37/100